CVS HEALTH CORPORATION Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CVS HEALTH CORPORATION payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00.
- CVS HEALTH CORPORATION payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- CVS HEALTH CORPORATION payments for repurchase of common stock for the quarter ending 2025-06-30 was $0.00.
- CVS HEALTH CORPORATION payments for repurchase of common stock for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CVS HEALTH CORPORATION payments for repurchase of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CVS HEALTH CORPORATION payments for repurchase of common stock for fiscal 2024 was $3.02B, a 50.25% increase from fiscal 2023.
- CVS HEALTH CORPORATION payments for repurchase of common stock for fiscal 2023 was $2.01B, a 42.51% decline from fiscal 2022.
- CVS HEALTH CORPORATION payments for repurchase of common stock for fiscal 2022 was $3.50B.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $0.00 10-K · filed 2026-02-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $0.00 derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$1.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | -$4.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $3.02B 10-K · filed 2026-02-10 |
| 2024-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.02B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $3.02B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $3.03B 10-Q · filed 2025-05-01 | $3.02B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.01B 10-K · filed 2026-02-10 |
| 2023-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.51B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.52B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $2.02B 10-Q · filed 2024-05-01 | $3.52B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $1.50B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $3.50B 10-K · filed 2025-02-12 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.00B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.00B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $2.00B 10-Q · filed 2023-05-03 | $2.00B derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $0.00 10-K · filed 2024-02-07 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |
| 2020-12-31 | $0.00 8-K · filed 2023-05-25 | |
| 2019-12-31 | $0.00 10-K · filed 2020-02-18 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-18 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $4.36B 10-K · filed 2020-02-18 |
| 2017-09-30 | $400.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.82B derived: sum of 4 quarters · filed 2019-08-08 |
| 2017-06-30 | $340.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $4.46B derived: sum of 4 quarters · filed 2019-08-08 |
| 2017-03-31 | $3.62B 10-Q · filed 2018-05-02 | $6.02B derived: sum of 4 quarters · filed 2019-08-08 |
| 2016-12-31 | $461.00M derived: 8-K 12 month − 10-Q 9 month · filed 2019-08-08 | $4.46B 8-K · filed 2019-08-08 |
| 2016-09-30 | $40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $5.13B derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-06-30 | $1.89B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.03B derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-03-31 | $2.07B 10-Q · filed 2017-05-02 | $5.06B derived: sum of 4 quarters · filed 2018-02-14 |
| 2015-12-31 | $1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $5.00B 10-K · filed 2018-02-14 |
| 2015-09-30 | $937.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $5.07B derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-06-30 | $927.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $4.93B derived: sum of 4 quarters · filed 2017-02-09 |
| 2015-03-31 | $2.01B 10-Q · filed 2016-05-03 | $5.21B derived: sum of 4 quarters · filed 2017-02-09 |
| 2014-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $4.00B 10-K · filed 2017-02-09 |
| 2014-09-30 | $800.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $4.50B derived: sum of 4 quarters · filed 2016-02-09 |
| 2014-06-30 | $1.20B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $5.23B derived: sum of 4 quarters · filed 2016-02-09 |
| 2014-03-31 | $801.00M 10-Q · filed 2015-05-01 | $4.38B derived: sum of 4 quarters · filed 2016-02-09 |
| 2013-12-31 | $1.70B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-09 | $3.98B 10-K · filed 2016-02-09 |
| 2013-09-30 | $1.52B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $2.60B derived: sum of 4 quarters · filed 2015-02-10 |
| 2013-06-30 | $355.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $3.08B derived: sum of 4 quarters · filed 2015-02-10 |
| 2013-03-31 | $393.00M 10-Q · filed 2014-05-02 | $3.91B derived: sum of 4 quarters · filed 2015-02-10 |
| 2012-12-31 | $329.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $4.33B 10-K · filed 2015-02-10 |
| 2012-09-30 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $4.45B derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-06-30 | $1.19B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $4.03B derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-03-31 | $810.00M 10-Q · filed 2013-05-01 | $3.34B derived: sum of 4 quarters · filed 2014-02-11 |
| 2011-12-31 | $448.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $3.00B 10-K · filed 2014-02-11 |
| 2011-09-30 | $1.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $2.55B derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $504.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $971.00M derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $467.00M 10-Q · filed 2012-05-02 | $1.08B derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $1.50B 10-K · filed 2013-02-15 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $2.44B derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $613.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $3.98B derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $887.00M 10-Q · filed 2011-05-05 | |
| 2009-12-31 | $938.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $2.48B 10-K · filed 2012-02-17 |
| 2009-09-30 | $1.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | |
| 2008-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $23.00M 10-K · filed 2011-02-18 |
| 2008-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | |
| 2007-12-29 | $5.37B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |